<dl id="gcvn0"><font id="gcvn0"></font></dl>

      <dl id="gcvn0"><ins id="gcvn0"></ins></dl>
      <li id="gcvn0"><s id="gcvn0"><strong id="gcvn0"></strong></s></li>

            1. <dl id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></dl>
            2. <li id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></li>

                        <menuitem id="gcvn0"><font id="gcvn0"><td id="gcvn0"></td></font></menuitem>

                        <output id="gcvn0"><ins id="gcvn0"></ins></output>

                      1. 来宝网Logo

                        热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

                        现在位置首页>技术资料首页>行业动态>实验室动态>联合国报告:大多数发展中国家不具备保障生物安全的能力

                        联合国报告:大多数发展中国家不具备保障生物安全的能力

                        济南鑫贝西生物技术有限公司2008年6月7日 15:57 点击:1556

                        2008年5月30日联合国大学主持的一项研究显示,世界上大约有100个发展中国家缺乏?#34892;?#31649;理和监督现代生物科技的使用,因此使世界受到?#29616;?#30340;生物安全威胁。报告说,非洲、中亚、大洋洲和加勒比海的大多数国家在管理和培训方面的缺失使得全球目前不可能具备一个保障生物安全的系统。

                          联合国大学主持的一项研究显示,世界上大约有100个发展中国家缺乏?#34892;?#31649;理和监督现代生物科技的使用,因此使世界受到?#29616;?#30340;生物安全威胁。报告说,非洲、中亚、大洋洲和加勒比海的大多数国家在管理和培训方面的缺失使得全球目前不可能具备一个保障生物安全的系统。

                          联合国大学的研究表明,在农业和其他领域使用生物科技非常普遍,且具有上升趋势。而科技、政策和执法方面的缺陷将使生物恐怖主义的散播成为一个潜在的危险。
                        Most Developing Countries Ill-equipped To Ensure Global Biosafety

                        ScienceDaily (May 28, 2008) — A two-year UN study of internationally funded training programmes in biotechnology and biosafety warns that as many as 100 developing countries are unprepared to effectively manage and monitor the use of modern biotechnologies, leaving the world community open to serious biosafety threats.
                         

                        The report, from the United Nations University Institute of Advanced Studies, says training and management deficiencies in most countries of Africa, Central Asia, Oceania and the Caribbean, "are so pervasive and broad that there is no effective international system of biosafety at the moment."

                        In addition, the global resources available from donor countries and agencies, already inadequate to help developing countries meet basic international agreement obligations, are being cut back. It is estimated that, over the past 15 years, just $135 million has been invested globally by public and private sources in capacity building in developing country.

                        The UNU-IAS assessment, released at this month's Conference of Parties to the Convention on Biological Diversity in Bonn, takes no sides on genetically modified organisms and other biotech-related controversies. It was designed simply to shed a neutral, independent and objective light on international biotechnology and biosafety training programmes intended to allow developing countries to make and implement informed choices.

                        Among other questions examined:

                        • Are current capacity building initiatives directed towards particular policy or regulatory outcomes?
                        • Do they drive the policy process in developing countries?
                        • Are capacity building initiatives in biosafety and biotech demand driven?
                        • How can integrated capacity building be provided given lack of international consensus about nature and extent of risks posed by Living Modified Organisms?
                        • Are regional approaches appropriate for capacity building in biosafety and biotech?
                        • Is there sufficient donor coordination to avoid inappropriate duplication?
                        • Are existing activities sustainable?
                        • How should capacity building differentiate between developing countries at different stages of uptake of modern biotech?
                        • How can capacity building gaps and problems be addressed?

                        Authors, Sam Johnston, Catherine Monagle, Jessica Green and Ruth Mackenzie say the use and prevalence of biotechnology in agriculture and other sectors seems certain to increase. And the widespread ratification of the world's Cartagena Protocol on Biosafety (CPB), which will mark the 5th anniversary of its coming into force on Sept. 11, 2008, "demonstrates the desire for biosafety measures to go hand in hand with the development of biotechnology."

                        However, they cite the lack of technical, policy and enforcement capacities in developing countries as "a potentially contributing factor to the spread of bioterrorism" -- the deliberate release of naturally-occurring or human-modified bacteria, viruses, toxins or other biological agents.

                        Among other points and observations:

                        • Globalization, resulting in the increasing flow of information, people and resources, has weakened the power of states to manage technology development and will make it harder to develop an effective international regime;
                        • The lack of capacities and the associated policy vacuum allow for vested interests to predominate, dampen support for research and create hesitation on the part of governments to properly engage with the issue;
                        • A country that lacks capacity is more likely to bring in very restrictive systems in order to counterbalance its deficiencies and undermines their ability to consider less contentious uses of biotechnology, such as in diagnostics, industrial enzymes, pollution remediation, combating drought and reversing salinity;
                        • The lack of capacity creates dependency in developing countries;
                        • The use of genetically-modified crops in many developing countries makes future trade bans and disruption likely;
                        • The lack of an effective biosafety regime undermines the potential for developing countries to consider the role of biotechnology in critical areas such as addressing climate change.

                        Most available capacity building resources to date have been devoted to developing policy and regulatory regimes, including approval procedures and risk assessment. Scientific training has focused mostly on risk assessment and, to a lesser extent, on the detection of genetically modified organisms.

                        The authors offer a suite of recommendations, emphasizing that capacity needs should be identified locally, not internationally, and point to success stories on which world efforts should be built.

                        The findings raise fundamental questions about "the extent to which capacity deficits are undermining the promise that advances in biotechnology would directly address the needs of the poor," says UNU-IAS Director A.H. Zakri.

                        "There may also be broader implications of a capacity deficit in biosafety and biotechnology. These may include an impaired ability to meet the challenges of global issues such as climate change, or to protect humans and the environment against biosecurity risks."

                        Information for the assessment was assembled from available literature and previous assessments, country visits to the Philippines, Uganda, Bangladesh and Cameroon, stakeholder interviews and participation in several international meetings, overseen by an advisory committee of senior experts and critiqued by a range of reviewers.

                        The full report is online at
                        http://www.ias.unu.edu/resource_centre/Internationally Funded Training in Biotechnology and Biosafety_Is it Bridging the Biotech Divide.pdf

                        (来源: 济南鑫贝西生物技术有限公司


                        全年征稿 / 资讯合作

                        联系邮箱:[email protected]

                        版权与免责声明

                        • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.ttui.tw,违反者本网将追究相关法律责任。
                        • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作?#38750;?#26435;行为的直接责任及连带责任。其他媒体、网站或个人从本网转载?#20445;?#24517;须保留本网注明的作品来源,并自负版权等法律责任。
                        • 如涉及作品内容、版权?#20219;?#39064;,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。

                        <dl id="gcvn0"><font id="gcvn0"></font></dl>

                          <dl id="gcvn0"><ins id="gcvn0"></ins></dl>
                          <li id="gcvn0"><s id="gcvn0"><strong id="gcvn0"></strong></s></li>

                                1. <dl id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></dl>
                                2. <li id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></li>

                                            <menuitem id="gcvn0"><font id="gcvn0"><td id="gcvn0"></td></font></menuitem>

                                            <output id="gcvn0"><ins id="gcvn0"></ins></output>

                                          1. 广东快乐10分走势

                                            <dl id="gcvn0"><font id="gcvn0"></font></dl>

                                              <dl id="gcvn0"><ins id="gcvn0"></ins></dl>
                                              <li id="gcvn0"><s id="gcvn0"><strong id="gcvn0"></strong></s></li>

                                                    1. <dl id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></dl>
                                                    2. <li id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></li>

                                                                <menuitem id="gcvn0"><font id="gcvn0"><td id="gcvn0"></td></font></menuitem>

                                                                <output id="gcvn0"><ins id="gcvn0"></ins></output>

                                                                <dl id="gcvn0"><font id="gcvn0"></font></dl>

                                                                  <dl id="gcvn0"><ins id="gcvn0"></ins></dl>
                                                                  <li id="gcvn0"><s id="gcvn0"><strong id="gcvn0"></strong></s></li>

                                                                        1. <dl id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></dl>
                                                                        2. <li id="gcvn0"><ins id="gcvn0"><thead id="gcvn0"></thead></ins></li>

                                                                                    <menuitem id="gcvn0"><font id="gcvn0"><td id="gcvn0"></td></font></menuitem>

                                                                                    <output id="gcvn0"><ins id="gcvn0"></ins></output>

                                                                                  1. 组三组六怎么买必赚 快乐时时彩计划表 今晚六 合 彩开奖 结果 澳洲幸运10是哪的 21点蛋糕 七星彩走势图表最新 宁夏十一选五下载 宁夏11选5手机号 肥牛牛贝斯 上海双色球2017号码分布图 甘肃快三开奖 北单奖金计算方法 九龙开奖90660a com 广东时时彩11选5走势图 福建36选7开奖彩票